Induction of primary NY-ESO-1 immunity: CD8+ T lymphocyte and antibody responses in peptide-vaccinated patients with NY-ESO-1+ cancers.

MLA

Jäger, E., et al. “Induction of Primary NY-ESO-1 Immunity: CD8+ T Lymphocyte and Antibody Responses in Peptide-Vaccinated Patients with NY-ESO-1+ Cancers.” Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 22, Oct. 2000, pp. 12198–203. EBSCOhost, https://doi.org/10.1073/pnas.220413497.

APA

Jäger, E., Gnjatic, S., Nagata, Y., Stockert, E., Jäger, D., Karbach, J., Neumann, A., Rieckenberg, J., Chen, Y. T., Ritter, G., Hoffman, E., Arand, M., Old, L. J., & Knuth, A. (2000). Induction of primary NY-ESO-1 immunity: CD8+ T lymphocyte and antibody responses in peptide-vaccinated patients with NY-ESO-1+ cancers. Proceedings of the National Academy of Sciences of the United States of America, 97(22), 12198–12203. https://doi.org/10.1073/pnas.220413497

Chicago

Jäger, E, S Gnjatic, Y Nagata, E Stockert, D Jäger, J Karbach, A Neumann, et al. 2000. “Induction of Primary NY-ESO-1 Immunity: CD8+ T Lymphocyte and Antibody Responses in Peptide-Vaccinated Patients with NY-ESO-1+ Cancers.” Proceedings of the National Academy of Sciences of the United States of America 97 (22): 12198–203. doi:10.1073/pnas.220413497.